tiprankstipranks
Trending News
More News >
Warby Parker (WRBY)
NYSE:WRBY
US Market

Warby Parker (WRBY) AI Stock Analysis

Compare
306 Followers

Top Page

WRBY

Warby Parker

(NYSE:WRBY)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
$27.00
▲(2.70% Upside)
Action:ReiteratedDate:02/27/26
The score is driven primarily by improving fundamentals and a constructive earnings outlook (strong revenue growth, turning cash flows positive, and guidance for further EBITDA margin expansion). Offsetting these positives are a very weak valuation profile (extremely high P/E) and only mixed technical momentum (negative MACD with otherwise neutral indicators).
Positive Factors
Sustained Revenue Scale
Multi-year revenue expansion reflects durable demand for Warby Parker’s vertically integrated, omnichannel model. Scaling revenue supports fixed-cost absorption, funds reinvestment and store growth, and indicates the company can continue capturing share in eyewear over the next 2–6 months.
Improving Cash Generation
Consistent, positive operating and free cash flow provides durable liquidity to fund store openings, product launches, and R&D (including AI glasses) without leaning heavily on debt. Strong cash generation also enables share buybacks and buffers macro shocks over the medium term.
Omnichannel Retail & Clinical Expansion
Aggressive store expansion plus growing clinical services (eye exams increased) deepen customer relationships and raise ARPC, creating durable unit economics advantages. Physical retail infill increases market penetration and creates synergy with online channels over the coming quarters.
Negative Factors
Gross Margin Pressure / Tariffs
Tariff-driven cost increases and shipping and mix shifts are structural margin headwinds that can erode durable profitability. If tariffs or supply-chain costs persist, margin recovery will require sustained pricing power or cost restructuring, challenging near-term margin stability.
Profitability Only Newly Positive
Net income that just turned positive signals earnings fragility: small adverse trends in mix, costs, or traffic could revert profits. Until margins consistently exceed break-even, capital returns and aggressive expansion carry execution risk over the next several quarters.
E‑commerce Transition & Younger‑Customer Softness
Digital program changes and weakened demand among younger, price‑sensitive cohorts create structural risk to online revenue and lifetime value. A sustained shift in customer behavior or slower digital recovery would pressure unit economics and require heavier marketing or product adjustments.

Warby Parker (WRBY) vs. SPDR S&P 500 ETF (SPY)

Warby Parker Business Overview & Revenue Model

Company DescriptionWarby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
How the Company Makes MoneyWarby Parker primarily generates revenue through the sale of prescription eyeglasses, sunglasses, and contact lenses. Its direct-to-consumer model allows the company to sell products at competitive prices, often significantly lower than traditional optical retailers. Key revenue streams include the sale of frames, lenses, and accessories, as well as the provision of eye exams in its retail locations. Additionally, the company has developed partnerships with various organizations and initiatives that enhance its brand visibility and customer reach. Warby Parker's innovative Home Try-On program, which allows customers to test frames at home before purchasing, also contributes to higher conversion rates and customer satisfaction, ultimately boosting sales.

Warby Parker Key Performance Indicators (KPIs)

Any
Any
Store Count
Store Count
Indicates the number of physical locations, reflecting the company's retail footprint and potential market reach. A growing store count can signal expansion efforts and increased brand presence.
Chart InsightsWarby Parker's aggressive store expansion strategy is evident, with a consistent increase in store count, reaching 300 locations by mid-2025. This growth aligns with their 19% retail revenue increase and strategic initiatives, including shop-in-shops in Target. The earnings call highlights a transformative partnership with Google for AI-powered eyewear, potentially broadening their market. However, challenges like tariff impacts and the phasing out of the home try-on program could affect margins and customer acquisition. The CFO's departure adds uncertainty to their financial leadership.
Data provided by:The Fly

Warby Parker Earnings Call Summary

Earnings Call Date:Feb 26, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The call presented a largely constructive operating and financial picture: the company delivered double-digit revenue growth, its first full year of net income profitability, accelerating free cash flow, meaningful adjusted EBITDA improvement, and an aggressive store expansion and AI strategy backed by strong partnerships. However, near-term pressures were highlighted, including margin headwinds from tariffs and mix shift, softer demand among younger consumers, weather-driven retail disruptions in Q1, and e-commerce impacts from phasing out the home try-on program. Management provided conservative 2026 guidance (10%–12% revenue growth and EBITDA margin expansion) and excluded any AI glasses revenue, positioning the company for upside if execution and market demand for AI products materialize. Overall, the positives in growth, profitability, balance sheet strength, and strategic initiatives outweigh the short-term operational and macro uncertainties discussed on the call.
Q4-2025 Updates
Positive Updates
Full-Year and Quarterly Revenue Growth
Fiscal 2025 revenue of $871.9M, up 13% year-over-year; Q4 2025 revenue of $212M, up 11.2% year-over-year. Retail revenue grew 17.3% for the year and 15.2% in Q4.
First Full Year of Net Income Profitability
Company reported its first full year of positive net income in 2025 while navigating tariffs and a dynamic consumer backdrop.
Adjusted EBITDA and Margin Improvement Guidance
Full-year 2025 adjusted EBITDA of $95M, up 30% year-over-year. 2026 guidance of $117M–$119M adjusted EBITDA, implying a 12.2% margin and ~130 basis points of margin expansion year-over-year.
Free Cash Flow and Strong Balance Sheet
Generated $44M in free cash flow in 2025 (up from $35M in 2024). Cash balance ended at $286M (+$32M YoY) and an undrawn $120M credit facility (expandable to $175M) provides liquidity.
Store Expansion and Retail Execution
Opened 47 stores in 2025 (most ever in a single year) and ended the year with 323 stores. Plan to open ~50 stores in 2026 with a long-term target of at least 900 stores; infill strategy driving higher customer growth in markets with more stores.
Customer Base and ARPC Growth
Active customers reached 2.7M (up 7% YoY on a TTM basis). Average revenue per customer increased 5.7% to $324 in 2025.
Expansion of Clinical Services and Higher-Value Mix
Eye exams grew ~37% in 2025 to represent ~6% of the business; exam capability in almost 90% of stores. Progressives represented ~22% of prescription units, highlighting an opportunity to increase higher-margin lens penetration.
AI Strategy, Partnerships, and Tech Investments
Preparing for AI 'Act Three' with partnership with Google and Samsung to launch AI glasses later in 2026; Google offsetting a large portion of prelaunch investment. AI now generates >50% of the company's code base; launched 'Advisor' recommendation engine in 2025. Guidance conservatively excludes AI glasses revenue.
Insurance Penetration Progress
In-network insurance penetration of ~8% in 2025 (up from 7% prior year), representing approximately 40% year-over-year dollar growth; initiatives to simplify out-of-network reimbursement showed promising pilot results.
E-commerce Underlying Strength Ex-Home Try-On
Sunsetting home try-on weighed on e-commerce; excluding home try-on, direct online glasses and contacts purchases grew in the mid-teens, indicating underlying digital demand and potential recovery as changes fully lap.
Negative Updates
Gross Margin Pressure
Full-year adjusted gross margin fell to 54.4%, down 110 basis points YoY; Q4 adjusted gross margin 52.5%, down 170 basis points YoY. Drivers included tariff-related headwinds, increased doctor headcount, expedited customer shipping costs, and mix shift into lower-price frames and higher contacts penetration.
Q4 Adjusted EBITDA Below Expectations
Q4 adjusted EBITDA was $15.2M (7.2% margin), coming in below the company's expectations due to softer December trends and some cadence-related expense timing (e.g., staffing doctors ahead of busy period).
Consumer Softness Among Younger Cohort
Noted softness concentrated in the 25–34 year-old cohort, with younger and lower-income consumers being more price-sensitive and pulling back—company sees this as category-wide but acknowledged actions to target younger consumers.
Industry Unit Declines and Category Volatility
Prescription glasses units declined ~6% industry-wide per The Vision Council; broader category volatility and transient softness pressured December trends and e-commerce performance.
Weather-Related Q1 Headwinds
Historic winter storms and prolonged cold heavily impacted high-volume East Coast stores (which generate >70% of retail sales), leading to store closures and lower traffic. Q1 2026 guidance assumes no further significant weather disruption and projects revenue of ~$238M–$240M.
Tariff Uncertainty
Tariff-related costs pressured margins in 2025. Recent Supreme Court ruling and subsequent proposed administration measures (e.g., global surcharge) create uncertainty; no tariff-related benefits were assumed in 2026 guidance.
E-commerce Growth Muted During Transition
E-commerce growth slowed (low single-digits for full year), with the decision to sunset the home try-on program creating a near-term headwind concentrated in the first half of 2026.
Mix Shift to Lower-Margin Categories
Increased penetration of lower-margin contact lenses and a shift into lower-price point frames partially offset price increases and pressured overall gross margin.
Conservative Near-Term Guidance Excludes AI Revenue
Management excluded any revenue contribution from AI glasses in 2026 guidance (though expenses for launch are included), meaning potential upside from the new product line is not reflected in the near-term outlook.
Company Guidance
Warby Parker guided 2026 revenue of $959–$976 million (about +10–12% YoY) and adjusted EBITDA of $117–$119 million (a 12.2% margin, ~+130 bps YoY), with gross margin expected roughly in line with 2025 (~54.4%), marketing in the low‑teens % of revenue, and e‑commerce growth in the low single digits; the company reiterated that this outlook excludes any AI‑glasses revenue but includes the operating and capital spend to launch them. For Q1 2026 it guided $238–$240 million in revenue and $27–$28 million adjusted EBITDA (~11.5% margin), noting quarter‑to‑date mid‑single‑digit top‑line growth and weather‑related retail headwinds concentrated on the East Coast. The plan contemplates ~50 new store openings in 2026 (323 stores at year‑end 2025; long‑term potential ≥900), continued scaling of eye exams (up 37% in 2025 to ~6% of sales), higher insurance penetration (in‑network ~8% in 2025, ~40% YoY dollar growth), and disciplined capital allocation supported by $286M cash, $44M free cash flow in 2025, a $120M credit facility (expandable to $175M), and a Board‑authorized share repurchase program up to $100M.

Warby Parker Financial Statement Overview

Summary
Strong multi-year revenue growth and meaningfully improved cash generation (2025 operating cash flow ~$111M; free cash flow ~$44M). However, profitability is only newly positive and still near break-even (2025 net margin ~0.2%), and leverage is manageable but not conservative (debt-to-equity ~0.63).
Income Statement
56
Neutral
Revenue has scaled materially over the period (from $394M in 2020 to $872M in 2025), showing strong top-line momentum. Gross margin remains solid and fairly steady in the mid-to-high 50% range, supporting the business model. However, profitability is still a weak spot: operating results were meaningfully negative in prior years and only recently improved to near break-even, with 2025 net margin just above zero (~0.2%). Overall, the trajectory is improving, but earnings quality and consistency are not yet proven.
Balance Sheet
60
Neutral
The balance sheet looks moderately levered with debt at ~$233M against equity of ~$368M in 2025 (debt-to-equity ~0.63), which is manageable but not conservative. Total assets have grown alongside the business, and equity has increased versus earlier years, indicating improving capitalization. The main concern is that shareholder returns have been weak/negative for most of the period, only turning slightly positive in 2025, which limits balance-sheet strength from a profitability standpoint.
Cash Flow
72
Positive
Cash generation has improved meaningfully. Operating cash flow rose from negative in 2021 to a strong ~$111M in 2025, and free cash flow turned decisively positive (about ~$44M in 2025) with solid growth year-over-year. Earlier years showed volatility, including notably negative free cash flow in 2021–2022, but the last three years demonstrate a clearer positive trend. A remaining watch item is that free cash flow is not consistently high relative to operating cash flow, suggesting ongoing reinvestment needs and/or working-capital swings.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue871.90M771.32M669.76M598.11M540.80M
Gross Profit470.58M426.83M365.22M341.06M317.75M
EBITDA53.32M15.75M-33.44M-78.03M-121.70M
Net Income1.64M-20.39M-63.20M-110.39M-144.27M
Balance Sheet
Total Assets720.92M676.49M580.31M568.71M440.65M
Cash, Cash Equivalents and Short-Term Investments286.36M254.16M216.89M208.59M256.42M
Total Debt233.15M225.35M174.46M173.38M0.00
Total Liabilities353.19M336.42M278.52M282.06M154.65M
Stockholders Equity367.73M340.07M301.79M286.65M286.00M
Cash Flow
Free Cash Flow43.74M34.71M7.32M-49.81M-80.51M
Operating Cash Flow110.78M98.74M60.99M10.37M-31.99M
Investing Cash Flow-67.05M-66.03M-54.67M-60.18M-48.51M
Financing Cash Flow-12.00M4.96M2.87M3.29M23.00M

Warby Parker Technical Analysis

Technical Analysis Sentiment
Positive
Last Price26.29
Price Trends
50DMA
25.20
Positive
100DMA
22.98
Positive
200DMA
23.44
Positive
Market Momentum
MACD
-0.21
Negative
RSI
57.51
Neutral
STOCH
72.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WRBY, the sentiment is Positive. The current price of 26.29 is above the 20-day moving average (MA) of 23.76, above the 50-day MA of 25.20, and above the 200-day MA of 23.44, indicating a bullish trend. The MACD of -0.21 indicates Negative momentum. The RSI at 57.51 is Neutral, neither overbought nor oversold. The STOCH value of 72.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for WRBY.

Warby Parker Risk Analysis

Warby Parker disclosed 67 risk factors in its most recent earnings report. Warby Parker reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Warby Parker Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
$3.23B2,172.730.46%14.55%
60
Neutral
$6.52B-18.07-4.69%6.23%17.53%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
$5.99M-0.43-74.10%53.22%72.69%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WRBY
Warby Parker
27.48
4.26
18.35%
BLCO
Bausch + Lomb Corporation
17.98
2.14
13.51%
LUCY
Innovative Eyewear, Inc.
1.13
-3.05
-72.97%

Warby Parker Corporate Events

Business Operations and StrategyStock BuybackFinancial Disclosures
Warby Parker Announces Buyback Amid Profitable Growth Milestone
Positive
Feb 26, 2026

On February 26, 2026, Warby Parker reported fourth quarter and full-year 2025 results showing net revenue up 13.0% to $871.9 million for the year and 11.2% in the quarter, supported by 7.0% active customer growth and a 5.7% rise in average revenue per customer to $324. The company achieved its first full year of positive net income at $1.6 million, expanded Adjusted EBITDA by 30.2% to $95.2 million with a 10.9% margin, and delivered its third consecutive year of positive operating and free cash flow, while ending 2025 with $286.4 million in cash and opening 47 net new stores to reach 323 locations.

Management highlighted that gross margin fell to 54.0% for 2025, pressured by tariffs, higher doctor headcount, contact lens mix, and shipping costs, though partially offset by selective price increases and greater penetration of progressives and lens enhancements. SG&A as a percentage of revenue declined materially due to cost leverage, operational efficiencies, and lower stock-based compensation, supporting margin improvement and signaling increased operating discipline as Warby Parker seeks to capture additional market share in a competitive, dynamic environment.

The board also authorized a share repurchase program of up to $100 million in Class A common stock in February 2026, providing a new capital return lever alongside ongoing investments in growth, including a planned pipeline of new stores. This move, enabled by a strong balance sheet and cash generation, underscores management’s confidence in the company’s long-term prospects and offers potential support for the stock, while preserving flexibility as the program has no fixed expiration and can be adjusted at the board’s discretion.

Co-founders Dave Gilboa and Neil Blumenthal framed 2025 as a pivotal year, noting that Warby Parker sustained double-digit revenue growth each quarter while transitioning to profitability and enhancing Adjusted EBITDA. They signaled a strategic push into a “next act” centered on innovation and AI to reshape the eyewear and vision-care experience, positioning the brand for accelerated growth as it continues to marry style, quality, and value with technology-driven customer experiences.

The most recent analyst rating on (WRBY) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Warby Parker stock, see the WRBY Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Warby Parker Appoints Adrian Mitchell as New CFO
Positive
Feb 9, 2026

On February 4, 2026, Warby Parker’s board appointed veteran retail executive Adrian Mitchell as Chief Financial Officer, effective February 10, 2026, with Co‑Founder Dave Gilboa continuing as Co‑CEO. The move, announced publicly on February 9, 2026, installs Mitchell as the company’s principal financial and accounting officer under a compensation package combining base salary, equity awards, and performance-based stock units.

Mitchell, formerly Chief Operating Officer and Chief Financial Officer at Macy’s Inc. and a past executive at Crate & Barrel, Arhaus, Target, McKinsey, and Boston Consulting Group, brings more than 25 years of experience leading large consumer brands and driving digital and operational transformation. Warby Parker frames his appointment as a way to bolster financial discipline and operating expertise as it pursues profitable growth, expands retail and product offerings, and deepens its push into new categories such as AI-enabled glasses, with implications for long-term shareholder value and execution of its mission-driven strategy.

The most recent analyst rating on (WRBY) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Warby Parker stock, see the WRBY Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
Warby Parker Partners with Google on AI Glasses
Positive
Dec 8, 2025

Warby Parker and Google have announced their collaboration on developing lightweight AI glasses, which are expected to launch in 2026. This partnership marks a significant step in Warby Parker’s product innovation strategy, potentially impacting its market position and offering new opportunities for stakeholders in the tech and eyewear industries.

The most recent analyst rating on (WRBY) stock is a Hold with a $20.50 price target. To see the full list of analyst forecasts on Warby Parker stock, see the WRBY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 27, 2026